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TANK-binding kinase-1 (TBK1) is an integral component of Type I interferon induction by microbial infection. The
importance of TBK1 and Type I interferon in antiviral immunity is well established, but the function of TBK1 in bacterial
infection is unclear. Upon infection of murine embryonic fibroblasts with Salmonella enterica serovar Typhimurium
(Salmonella), more extensive bacterial proliferation was observed in tbk1
 / than tbk1
þ/þcells. TBK1 kinase activity was
required for restriction of bacterial infection, but interferon regulatory factor-3 or Type I interferon did not contribute
to this TBK1-dependent function. In tbk1
 / cells, Salmonella, enteropathogenic Escherichia coli, and Streptococcus
pyogenes escaped from vacuoles into the cytosol where increased replication occurred, which suggests that TBK1
regulates the integrity of pathogen-containing vacuoles. Knockdown of tbk1 in macrophages and epithelial cells also
resulted in increased bacterial localization in the cytosol, indicating that the role of TBK1 in maintaining vacuolar
integrity is relevant in different cell types. Taken together, these data demonstrate a requirement for TBK1 in control
of bacterial infection distinct from its established role in antiviral immunity.
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Introduction
Host organisms employ a multitude of innate defense
mechanisms against invading microbial pathogens. Functions
of the innate immune system include control and destruction
of pathogens and instruction of the developing adaptive
immune response through expression of cytokines, chemo-
kines, and other proinﬂammatory molecules [1,2]. Innate
recognition of invading pathogens can occur through pattern
recognition receptors, such as Toll-like receptors (TLRs),
which bind to molecules characteristic of microbial organ-
isms like lipopolysaccharide (LPS) [3]. Two well-characterized
signaling pathways associated with TLR stimulation are the
MyD88-dependent pathway, which primarily results in NFjB
activation, and the TANK-binding-kinase-1 (TBK1)-depend-
ent pathway that induces transcription of Type I interferon
genes [4]. The importance of the MyD88-dependent pathway
in antibacterial immunity is well established, but the func-
tional contribution of TBK1-dependent signaling in protect-
ing against bacterial infection is unknown [3].
TBK1, also termed NFjB-activating kinase or TRAF2-
associated kinase, is a ubiquitous member of the IjB kinase
(IKK) family that is required for embryonic development [5–
7]. Upon microbial infection or LPS treatment, TBK1
phosphorylates the transcription factor interferon regulatory
factor-3 (IRF3), resulting in IRF3 translocation into the
nucleus and transcription of target genes, such as ip10 (IFN-
gamma inducible protein 10), ifnb (interferon beta; a Type I
interferon), and subsequent interferon response genes such
as mx1 [8–10]. TBK1 is required for optimal induction of ifnb
and Type I interferon-dependent antimicrobial effector
mechanisms during viral infection [11]. Induction of TBK1-
dependent signaling by viruses has been extensively studied
and occurs upon viral recognition by TLRs or upon cytosolic
binding of viral double-stranded RNA by the DEAD-box
helicases, RIG-I and MDA5 [12–16]. Gram-negative bacterial
infections can also trigger TBK1-dependent interferon
induction by association of LPS with the TLR4 signaling
complex [10,17]. In contrast, extracellular Gram-positive
bacteria do not activate expression of interferon genes,
although cytosolic Gram-positive bacteria can upregulate ifnb
transcription in an IRF3-dependent manner [18,19].
To investigate the requirement for TBK1 in response to
bacterial infection, we used Salmonella enterica serovar
Typhimurium as a model Gram-negative bacterium. Salmo-
nella is a facultative intracellular pathogen that replicates
within macrophages and non-phagocytic cells [20,21]. Salmo-
nella invades non-phagocytic cells by secreting effector
proteins through a syringe-like Type III secretion system
(T3SS) encoded on Salmonella pathogenicity island-1 (SPI-1) to
induce membrane rufﬂing and bacterial uptake [22]. After
entry into the host cell, Salmonella resides in a membrane-
bound compartment termed the Salmonella-containing va-
cuole (SCV). Subsequent to invasion, the SCV progresses
through early stages of endocytic maturation and acquires
the late endosomal marker, lysosomal-associated membrane
protein 1 (LAMP-1) [23]. At this stage, the SCV can diverge
from the endocytic pathway by avoiding lysosome fusion and
can localize to the perinuclear region [24]. Many Salmonella
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of bacteria escape into the host cytosol where they acquire
host-derived ubiquitin [25].
Like viruses, intracellular bacterial pathogens exploit the
host cell as a replicative niche. By analogy to known antiviral
immune mechanisms, we hypothesized that TBK1 would also
protect host cells from infection by intracellular bacterial
pathogens. However, speciﬁc effector mechanisms of antiviral
innate immunity, such as Type I interferon-dependent
induction of 2–59 oligoadenylate synthase, which facilitates
viral RNA degradation, would not necessarily be effective
against intracellular bacteria [26]. Since loss of TBK1 results
in embryonic lethality, we used tbk1
þ/þ and tbk1
 /  mouse
embryonic ﬁbroblasts (MEFs) or RNAi to test the requirement
for TBK1 during bacterial infection. Here, we show that
TBK1 mediates an early cellular response to infection by
Salmonella and other bacteria by maintaining these pathogens
in a restrictive vacuolar compartment.
Methods
Bacterial Strains and Cell Culture
Strains used in this study are described in Table S1.
Salmonella strains expressing green ﬂuorescent protein (GFP)
were constructed by electroporating the bacteria with
pFPV25.1 obtained from C. Detweiler [27]. The Salmonella
strain expressing red ﬂuorescent protein (RFP) was con-
structed by amplifying the RFP gene from pGEM:RFP (J. A.
Bauer, University of Michigan Medical School), ligating the
sequence into PCR-II-Topo (Invitrogen, http://www.invitro-
gen.com), and then electroporation into Salmonella. MEFs
were obtained from W. C. Yeh (tbk1
þ/þ and tbk1
 / ) and K.
Mossman and B. Williams (irf3
þ/þ and irf3
 / ). MEFs and
RAW264.7 cells (American Type Culture Collection) were
grown in RPMI medium supplemented with 10% fetal bovine
serum and 1% L-glutamine at 37 8Ci n5 %C O 2. Experiments
in tbk1
þ/þ and tbk1
 /  MEFs were reproduced both with
primary MEFs in early passage and with MEFs that were
immortalized by continuous culture and clonally derived.
HeLa cells (ATCC) were grown in MEMa medium supple-
mented with 10% fetal bovine serum, 1% L-glutamine, 1%
nonessential amino acids, and 1% sodium pyruvate at 37 8C
in 5% CO2.
Infections
All Salmonella strains were grown overnight in LB medium at
37 8C, shaking and back-diluted 1:100. When the bacteria
reached exponential phase, they were washed twice with
Dulbecco’s PBS (D-PBS) and used to infect MEFs at a
multiplicity of infection (m.o.i.) of 10 for 1 h, whereupon
infected cells were washed three times with D-PBS and
incubated in medium containing 100 lg/ml gentamicin for 2
h.ThecellswerethenwashedthreetimeswithD-PBSandfresh
medium containing 5 lg/ml gentamicin was added. For
intracellular growth curves, at indicated times post-infection
(p.i.),threecoverslipscontaininginfectedMEFswereremoved
and individually lysed in 5 ml sterile water; a fraction of the
lysate was plated on LB agar to enumerate colony-forming
units. St SPI-1
  required bystander infection with wild-type
Salmonella; coinfections were performed with Salmonella grown
and infected under the same conditions as stated for
monotypic Salmonella infection in MEFs, except that the St
SPI-1
 mutant was added at an m.o.i. of 100. Enteropathogenic
Escherichiacoli(EPEC)wasgrownstaticallyovernightinLBat25
8C, then back-diluted 1:100, and incubated shaking at 37 8Ci n
serum-free DMEM for 1 h. EPEC were then used to infect MEF
cells at an m.o.i. of 25 for 1 h; washing and gentamicin
treatment were carried out as described for Salmonella.
Streptococcus pyogenes were statically grown overnight at room
temperature in BHI. The stationary phase bacteria were
washed two times with PBS, vigorously vortexed, and used to
infect MEFs at an m.o.i. of 25. The remainder of the infection
wasdoneunderthesameconditionsasdescribedforSalmonella
infection in MEFs. Bacterial infections in transfected HeLa
cells were performed as described for MEFs, except that
Salmonella and S. pyogenes were incubated with the host cells for
30minatanm.o.i.of100andEPECatanm.o.i.of50for1h;the
HeLa cells were washed three times with D-PBS and incubated
with fresh medium for 30 min before gentamicin was added.
Infections of RAW264.7 macrophages were performed with
Salmonella at an m.o.i. of 10 for 30 min, EPEC at an m.o.i. of 50
for 45 min, and S. pyogenes at an m.o.i. of 25 for 30 min. The
macrophages were washed three times with D-PBS, and
medium with gentamicin added as described for MEFs. 2-lm
beads were incubated with anti-streptavidin antibody in D-
PBSþ1% BSA for 30 min, then washed three times in D-PBSþ
1% BSA, added to the macrophage culture, and spun down
onto the macrophage monolayer. Beads were incubated with
the macrophages for 30 min and then the cells were washed
three times with D-PBS before adding fresh medium.
Transfections
HeLa cells or MEFs were re-suspended in the appropriate
growth medium as described above and plated in a 6-well
plate at a concentration of 5 3 10
5 cells/plate. Cells were
transfected for 24 h with either 4.2 lg of plasmid DNA or 40
lM of the indicated short interfering RNA (siRNA) (Ambion,
http://www.ambion.com) complexed with Lipofectamine 2000
(Invitrogen, http://www.invitrogen.com). For siRNA experi-
ments, transfected cells were trypsinized, split 1:2, and
subjected to a second round of siRNA transfection as above,
until time of harvest or infection with Salmonella. For
transfection of RAW264.7 macrophages, cells were re-
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Author Summary
Early control of invading microbial pathogens is an essential
function of the host response to infection. Previous studies have
shown that upon viral infection, a protein called TANK-binding
kinase-1(TBK1) signals the induction of a program of protection that
results in inhibition of viral replication. During infection of
mammalian cells by bacteria, a different type of microbe than a
virus, TBK1 also sends signals, but the functional contribution of
TBK1 to controlling bacterial infection was unknown. Here, we show
that TBK1 does protect host cells from bacterial infection; however,
the TBK1-dependent mechanisms that inhibit viral infection were
not effective against bacterial growth. Instead, TBK1 maintained the
integrity of the vacuolar compartment, consisting of small
membrane-bound vesicles, where the invading bacteria were
trapped. In the absence of TBK1, pathogens such as Salmonella,
enteropathogenic Escherichia coli, and Group A Streptococcus were
able to escape from the confining host vacuoles and grow to high
levels within the host cytosol. Thus, TBK1 plays an important role in
the cellular response to bacterial infection, distinct from its function
in antiviral immunity.suspended in growth medium as described above and plated
in a 6-well plate at a concentration of 1 3 10
6cells/plate.
Macrophages were transfected as described for HeLa and
MEF cells.
Microscopy
Cells were grown in appropriate medium in a 6-well
plate at a concentration of 7 3 10
5 cells/plate and infected
as described above. At indicated times p.i., cover slips were
removed and ﬁxed in 3.7% paraformaldehyde in D-PBS.
Cells were then washed three times with 0.1% Triton X-100
in PBS and blocked for 10 min with TBS-TX (25 mM Tris-
HCl [pH 8.0], 150 mM NaCl, 0.1% Triton X100, 1% BSA).
TBS-TX with primary antibody was added to the cells for 1
h. Cells were then rinsed three times with TBS-TX and
incubated for 30 min with secondary antibody. Cover slips
were rinsed with TBS-TX and mounted with Pro-Long Gold
Antifade (Invitrogen). Samples were analyzed with the
Olympus Fluoview FV-500 (http://www.olympus.com) con-
focal microscope using a 1003 objective, unless otherwise
stated, and Fluoview software. Quantitation of bacteria
colocalized with LAMP-1 or ubiquitin was performed by
scoring 150 randomly chosen bacteria per experiment for
the presence of LAMP-1 or ubiquitin; only bacteria
completely surrounded by LAMP-1 or ubiquitin as in-
dicated by antibody staining were scored as colocalized.
Transmission electron microscopy was performed on a
Philips CM-100 transmission electron microscope equipped
with automated compustage and Kodak 1.6 Megaplus
(http://www.kodak.com) high-resolution digital camera. Sam-
ples were prepared as previously described [28].
Antibodies and Reagents
The LAMP-1 (1D4B) rat monoclonal antibody was obtained
from Santa Cruz Biotechnology (http://www.scbt.com), the
anti-ubiquitin monoclonal antibody (FK2) from BIOMOL
International (http://www.biomol.com), the anti-TBK1 mono-
clonal antibody from Imgenex (http://www.imgenex.com), and
anti-streptavidin antibody from Molecular Probes (http://
probes.invitrogen.com). TRITC-phalloidin was purchased
from Invitrogen and 49,6-Diamidino-2 phenylindole dihydro-
chloride (DAPI) from BioChemika (http://www.sigmaaldrich.
com). Recombinant mouse interferon-b (PBL Biomedical
Laboratories, http://www.pblbio.com) was used at 100 U/ml
to treat cells overnight and throughout the course of
infection. Lysotracker Red DND-99 (Invitrogen) was a gift
from K. Collins (University of Michigan Medical School).
Alpha-amanitin (BioChemika) was used at 50 lg/ml to pre-
treat cells for 1 h prior to and during the course of infection.
All siRNA reagents were obtained from Ambion. The EGFP-
LC3 was obtained from Addgene, Incorporated (plasmid
11546) (http://www.addgene.com) and constructed in the
laboratory of K. Kirkegaard. Beads and anti-streptavidin
antibody were a gift from J. Swanson (2.01-lm streptavidin
silicon oxide microspheres; Corpuscular, Cold Spring, New
York, United States).
Construction of TBK1-KD
The tbk1 cDNA ampliﬁed from tbk1
þ/þMEF RNA was cloned
into the expression vector pcDNA3 (Invitrogen). After
sequence validation, QuikChange mutagenesis [29] was
performed to replace lysine-38 with an alanine, which was
validated by sequencing. TBK1:pcDNA3 and TBK1-
KD:pcDNA3 both encoded a full-length TBK1 protein as
determined by TNT Quick Coupled Transcription/Trans-
lation Systems (Promega, http://www.promega.com) and West-
ern blot probed with anti-TBK1 antibody.
Real Time Quantitative RT-PCR and Sequence Information
Total RNA was isolated from cells using the RNAeasy kit
(Qiagen, http://www1.qiagen.com) and cDNA synthesis carried
out using 2.5 lg of total RNA (M-MLV Reverse Transcriptase;
Invitrogen). Real time RT-PCR analysis was performed with
the MX3000p (Stratagene, http://www.stratagene.com) and
Brilliant SYBR Green MasterMix (Stratagene). Relative
amounts of cDNA were normalized to actin cDNA levels in
each sample. The following primers were used for ampliﬁca-
tion: ip10 (F- 59ATGAGGGCCATAGG GAAGCTTGAA; R-
59ACCAAGGGCAATTAGGACTAGCCA),mx1(F-59TTGTCTA
CTGCCAGGACCAGGTTT; R-59 TTTCAGGTGCTGGGT-
CATCTCAGT), actin (F-59AGGTGTGATGGTGGGAATGG; R-
59GCCTCGTCACCCACATAGGA).
Results
TBK1 Restricts Intracellular Infection by Salmonella
To investigate the role of TBK1 in the cellular response to
bacterial infection, we infected tbk1
þ/þ and tbk1
 /  MEFs with
Salmonella expressing GFP. Salmonella invaded the wild-type
and mutant MEFs similarly; however, at 8 h p.i., the
monolayer of tbk1
 /  MEFs contained approximately 10-fold
more bacteria than the wild-type MEFs (Figure 1A and 1B).
Robust bacterial proliferation was observed in 35%–40% of
infected tbk1
 /  MEFs, which was consistent with immuno-
ﬂuorescence analysis of individual cells showing a more
pronounced phenotype than that observed by measuring net
increase in bacterial numbers. By immunoﬂuorescence
analysis, the remainder of the tbk1
 /  infected MEFs appeared
similar to tbk1
þ/þ infected MEFs (Figure 1A; 403 magniﬁca-
tion). Infected tbk1
 /  MEFs that did not exhibit greater
bacterial proliferation might have undergone an unproduc-
tive infection, since at 1 h p.i., 20%–30% of the bacteria in
either wild-type or mutant MEFs were found in autophago-
somes, and an additional 25%–30% in lysosomes, which are
likely nonreplicative compartments (Figure S1A and S1B).
The increased bacterial growth observed in tbk1
 /  MEFs was
not suppressed by addition of exogenous Type 1 interferon,
nor was a similar phenotype observed when Salmonella
infection was compared in irf3
þ/þ and irf3
 /  MEFs (Figures
1B, 1C, and S2A). Inhibition of de novo transcription and
translation also had no effect on the phenotype (Figure S2B
and S2C; unpublished data). However, the robust bacterial
replication in tbk1
 /  MEFs was substantially decreased by
transient transfection with a plasmid expressing wild-type
TBK1, but not a kinase dead mutant protein (TBK1 KD) [6]
(Figure 1D). Together, these data indicate that TBK1 kinase
activity limits intracellular infection of Salmonella independ-
ently of the IRF3-Type I interferon axis.
Salmonella Escapes from the Endocytic Pathway in the
Absence of TBK1
Previous studies have shown that shortly after invasion,
SCV colocalize with the late endosomal marker, LAMP-1 [24].
To determine the nature of the Salmonella-containing
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Salmonella-GFP and analyzed the samples by confocal immu-
noﬂuorescence microscopy using an anti-LAMP1 antibody
(Figures 2A and S3). SCV in tbk1
þ/þ cells were colocalized with
LAMP-1 throughout the entire course of infection, with
94.5% colocalization at 2 h p.i. In contrast, as early as 90 min
p.i. in tbk1
 /  cells, individual Salmonella lost association with
LAMP-1, and at 2 h p.i., only 63.0% of bacteria exhibited
colocalization. Loss of LAMP-1 colocalization by individual
bacteria was commonly observed early in infection, suggest-
ing that replication per se was not required for this abnormal
phenotype. Thus, in the absence of TBK1, many SCV lose the
late endosomal marker, LAMP-1, and deviate from the
characterized Salmonella endocytic trafﬁcking pathway.
Because Salmonella in TBK1-deﬁcient cells were found in a
LAMP-1 negative compartment dispersed throughout in-
fected cells, we reasoned that the bacteria might be in the
host cytosol. It was recently reported that under circum-
stances when Salmonella was found in the cytosol, the bacteria
associated with host ubiquitin [25]. Therefore, we infected
MEFs with Salmonella-GFP and analyzed the cells by confocal
immunoﬂuorescence microscopy to determine whether bac-
teria were colocalized with ubiquitin (Figure 2B). In tbk1
þ/þ
cells, 0.7% of Salmonella colocalized with ubiquitin at 4 h p.i.;
almost all of the bacteria remained in LAMP1
þ SCV during
the course of infection. In contrast, substantial numbers of
Salmonella in tbk1
 /  MEFs associated with ubiquitin (37.1% by
4 h p.i.), suggesting that Salmonella was released from the SCV
into the cytosol. However, the possibility remained that the
SCV was perforated; allowing access to cytosolic ubiquitin,
but the vacuolar membrane remained around each bacte-
rium. We directly visualized Salmonella in infected MEFs by
transmission electron microscopy and found that by 1 h p.i.
in tbk1
 /  cells, 66.7% of bacteria (n¼30) were surrounded by
vacuolar space, compared to 87.5% of bacteria (n ¼ 24) in
tbk1
þ/þ cells (Figure 2C). From these data, it was not clear
whether TBK1 regulated general integrity of the endocytic
pathway, or whether infection speciﬁcally triggered a TBK1-
dependent process. To test the general function of the
endocytic compartment, we measured internalization and
degradation of I
125-labeled epidermal growth factor (EGF) in
the absence of infection (Figure 2D). We would predict (based
Figure 1. TBK1 Kinase Activity Suppresses Salmonella Intracellular Growth
(A) MEFs were infected with Salmonella-GFP (green), fixed at 8 h p.i., counterstained with TRITC-phalloidin to visualize actin (red), and then analyzed by
confocal immunofluorescence microscopy. Images were acquired using either a 1003 or 403 objective.
(B) Salmonella intracellular growth was measured over time in tbk1
þ/þ (gray triangles) and tbk1
 /  (black squares) MEFs in the absence (solid lines) or
presence (dashed lines) of Type I interferon. Where indicated, MEFs were treated with 100 U/ml rIFN-b prior to and during infection. The data are
representative of five independent experiments.
(C) Salmonella intracellular growth in irf3
þ/þ (gray triangles) and irf3
 /  (black squares) MEFs was measured over time. The data are representative of
three independent experiments.
(D) MEFs were transfected with vector alone (pcDNA3), pcDNA3:TBK1, or pcDNA3:TBK1-KD where indicated in combination with pcDNA3:GFP as a
marker for transfection. Percent infected cells that contained .10 Salmonella, out of 150 infected cells counted per experiment at 8 h p.i., was
determined by fluorescence microscopy using DAPI to identify bacteria (n   3). Quantitation was limited to GFP-positive (transfected) MEFs. * and **
denote statistical significance of p   0.05 and 0.001, respectively, according to a one-tailed Student t-test comparing each tbk1
 / sample to the tbk1
þ/þ
control.
doi:10.1371/journal.ppat.0030029.g001
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TBK1 Restricts Bacterial Infectionon earlier studies) that general loss of integrity of the
endocytic pathway would affect lumenal pH and therefore
the ability to degrade proteins taken up by endocytosis, such
as EGF [30]. Endocytic uptake and processing of the radio-
labeled EGF appeared similar in both tbk1
þ/þand tbk1
 / MEFs,
demonstrating that escape of Salmonella into the cytosol of
TBK1-deﬁcient cells was not the result of general destabiliza-
tion of the endocytic compartment. Therefore, TBK1 con-
trols an early response to Salmonella infection that maintains
integrity of the pathogen-containing vacuole.
TBK1 Modulates Vacuolar Integrity in Response to Gram-
Negative and Gram-Positive Bacterial Invasion
Since known mediators of TBK1-dependent signaling were
not required to suppress intracellular bacterial growth, and
endocytic function was not generally compromised, we
Figure 2. In the Absence of TBK1, Bacteria Enter the Host Cytosol
(A) Tbk1
þ/þand tbk1
 / MEFs were infected with Salmonella-GFP (green). Infected cells were fixed at 2 h p.i., stained with anti-LAMP-1 antibody followed
by a TRITC-labeled secondary antibody (red), and analyzed by confocal immunofluorescence microscopy. Percent colocalization was determined by
counting the number of bacteria out of 150 bacteria per experiment that colocalized with LAMP-1. The experiment shown is representative of three
independent experiments.
(B) MEFs were infected for 1 h with the Salmonella-GFP (green), fixed at 4 h p.i., and stained with an anti-ubiquitin monoclonal antibody followed by a
TRITC-labeled secondary antibody (red). The percent of ubiquitin-associated bacteria was determined by counting the number of bacteria out of 150
bacteria per experiment that colocalized with ubiquitin as observed by confocal microscopy. The experiment shown is representative of three
independent experiments.
(C) Transmission electron microscopy was performed on MEFs infected for 1 h with Salmonella, and images acquired at 64,0003magnification. White
arrowheads point to bacterial membranes, black arrowheads point to host vacuolar membranes, and arrows point to bacteria no longer completely
surrounded by vacuolar membranes.
(D) MEFs were incubated with
125I-EGF and the rate of endocytic uptake (cell associated), degradation (TCA soluble), and accumulation of undegraded
product (TCA insoluble) was determined at 0.5, 1, 2, and 3 h after endocytosis. The data represent the mean of four independent experiments.
doi:10.1371/journal.ppat.0030029.g002
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process that requires TBK1. Salmonella contains two Type III
secretion systems encoded on SPI-1 (termed SPI-1 T3SS) and
SPI-2 (SPI-2 T3SS) that enable the bacterium to secrete
proteins directly into the host cell cytosol [22,31]. The SPI-1
T3SS is required for entry into non-phagocytic cells and
modulation of endosomal trafﬁcking; later in infection, SPI-2
T3SS-dependent effectors act to regulate membrane dynam-
ics. We tested the possibility that Type III secretion might
contribute to triggering the phenotype observed in TBK1-
deﬁcient MEFs. Salmonella strains deﬁcient in either the SPI-1
(St SPI-1
 ) or SPI-2 (St SPI-2
 ) encoded T3SS were assessed for
their ability to replicate within MEFs and access the host
cytosol (Figure 3A and 3B). The SPI-2 deﬁcient bacteria
proliferated similarly to wild-type Salmonella in both tbk1
þ/þ
and tbk1
 /  MEFs. We also analyzed a Salmonella mutant
lacking the SPI-2-dependent effector SifA, which exhibits
defects in SCV integrity [32–34]. If SifA and TBK1 were acting
in concert, we would expect StDsifA to proliferate equally in
tbk1
þ/þ and tbk1
 / cells; however, we still observed increased
cytosolic localization and replication by the mutant bacteria
in tbk1
 /  MEFs (Figure S4A and S4B). In contrast, the SPI-1-
deﬁcient bacteria (tet
R), induced to enter independent
vacuoles through bystander infection with wild-type Salmo-
nella (tet
S), as measured by tet
R colony-forming units or
immunoﬂuorescence, were unable to replicate in host cells of
either genotype and were never released in the cytosol
(Figures 3A, 3B, and S5) [35]. A double SPI-1
  SPI-2
  mutant
behaved similarly to the SPI-1
  single mutant (unpublished
data). These data suggest that a function associated with the
Salmonella SPI-1 T3SS stimulates TBK1-dependent modula-
tion of the pathogen-containing vacuole.
To determine whether vacuolar escape in tbk1
 / cells
required a Salmonella-speciﬁc process, we used an invasive
strain of EPEC, another Gram-negative bacterium, to infect
MEFs and determined subcellular localization by quantitating
colocalization with LAMP-1 (Figure 3C) [36]. LAMP-1
colocalization of EPEC was substantially decreased in tbk1
 / 
cells, similar to the phenotype we previously observed in
Salmonella infection, and increased bacterial replication was
Figure 3. TBK1 Protects Vacuolar Integrity in Response to Bacterial Infection
(A) Intracellular growth of wild-type or mutant Salmonella strains in tbk1
þ/þ(triangles) and tbk1
 / (squares) MEFs was measured over time. An antibiotic
resistant SPI-1-deficient strain (short dashed lines) was coinfected with an antibiotic-sensitive wild-type Salmonella strain to facilitate invasion by the
mutant. Only antibiotic resistant colonies are shown for the SPI-1
  growth curve.
(B) MEFs were infected with Salmonella-GFP and fixed at 2, 3, and 4 h p.i. In the case of coinfection (St SPI-1
 þSalmonella), the SPI-1-deficient strain was
marked with GFP. The samples were stained as described in Figure 2B. Percent ubiquitin-associated bacteria in tbk1
þ/þ MEFs (gray) or tbk1
 /  MEFs
(black) was calculated based on 150 bacteria counted that colocalized with ubiquitin from two to three independent experiments; * and ** denote p  
0.05 and 0.001, respectively, according to a two-tailed Student t-test.
(C) MEFs were infected for 1 h with the indicated bacteria and then fixed at 4 h p.i. Samples were subjected to immunofluorescence staining as
described in Figure 2A. Percent LAMP-1-associated represents the number of bacteria out of 150 counted per experiment that colocalized with LAMP-1
from three independent experiments; * and ** denote p   0.05 and 0.001, respectively, according to a two-tailed Student t-test.
(D) Transmission electron microscopy was performed on MEFs infected for 1 h with Streptococcus, and images were acquired at 64,0003magnification.
White arrowheads point to bacterial membranes, black arrowheads point to host vacuolar membranes, and black arrows point to bacteria that are no
longer completely surrounded by vacuolar membranes.
doi:10.1371/journal.ppat.0030029.g003
PLoS Pathogens | www.plospathogens.org March 2007 | Volume 3 | Issue 3 | e29 0006
TBK1 Restricts Bacterial Infectionobserved compared to tbk1
þ/þ MEFs (Figures 3C and S4C). We
also investigated subcellular localization of S. pyogenes, an
invasive Gram-positive bacterium, and found reproducibly
that the streptococci were found less often in a LAMP-1
þ
compartment in TBK1-deﬁcient cells, although the difference
between tbk1
 /  and tbk1
þ/þ MEFs was not as striking as that
observed for Gram-negative bacteria (Figure 3C). In addition,
transmission electron microscopy revealed that at 1 h p.i.,
fewer S. pyogenes were contained in vacuoles in tbk1
 /  MEFs
(50%; n¼30) than in tbk1
þ/þMEFs (91.5%; n¼47) (Figure 3D).
These results demonstrate that TBK1 is necessary for
restricting Gram-negative bacteria to the endocytic compart-
ment during infection and may also play a similar role during
cellular invasion by Gram-positive bacteria.
TBK1 Prevents Bacterial Entry into the Cytosol of Epithelial
Cells and Macrophages
MEFs represent an amenable genetic system with which to
test the role of TBK1 during bacterial infection in the
absence of a gene-deﬁcient live animal model; however, they
are not a cell type that would be present during a
physiological infection. To establish that loss of TBK1 caused
a speciﬁc defect in response to bacterial infection, we used an
RNAi approach to knock down TBK1 expression in HeLa
cells, an epithelial cell line commonly used to study Salmonella
pathogenesis, and used the treated cells to examine bacterial
growth and compartmentalization. HeLa cells were trans-
fected with tbk1 siRNA, gapdh siRNA, or a nonspeciﬁc siRNA
control for 72 h prior to infection; knockdown of TBK1 and
GAPDH was conﬁrmed by immunoblot analysis (Figure 4A;
unpublished data). HeLa cells treated with tbk1 siRNA
supported increased replication of Salmonella compared to
control treated cells, as observed in tbk1
 /  MEFs (Figure 4A).
Consistent with our previous observations in MEFs, 27.8% of
bacteria in tbk1 siRNA-treated HeLa cells were associated
with ubiquitin compared to 2.2% of bacteria in cells
transfected with control siRNA (Figure 4B and 4C). No
signiﬁcant increase in ubiquitin-associated bacteria was
observed with knockdown of GAPDH. IRF3 was also knocked
down by siRNA in HeLa cells; the validated knockdown had
no effect on Salmonella growth or ubiquitin association
(unpublished data). At 4 h p.i., HeLa cells transfected with
tbk1 siRNA had signiﬁcantly lower numbers of Salmonella,
EPEC, or S. pyogenes associated with LAMP-1 compared to the
control transfection (Figure 4D). These data demonstrate that
TBK1-dependent maintenance of vacuolar integrity is not a
MEF-speciﬁc phenomenon, but also protects epithelial cells
during bacterial infection.
Figure 4. TKB1 Knockdown in Epithelial Cells Phenocopies TBK1 Deficiency in MEFs
(A) HeLa cells were transfected with the indicated siRNA, and knockdown at 72 h p.i. was determined by Western blot analysis using an anti-TBK1
antibody: lane (1) no siRNA, lane (2) scrambled siRNA, lane (3) tbk1 siRNA (inset). Blots were re-probed with anti-actin antibody as a loading control.
HeLa cells were transfected with tbk1 or control siRNA and then infected by Salmonella to measure intracellular growth over time; * and ** denote p  
0.05 and 0.001, respectively, according to a one-tailed Student t-test comparing tbk1 siRNA with control siRNA-treated cells at each time point.
(B) HeLa cells transfected with tbk1-specific or control siRNA were infected with Salmonella-GFP. Samples were fixed at 4 h p.i., stained with anti-
ubiquitin antibody followed by a TRITC-labeled secondary antibody (red), and analyzed by confocal microscopy. The experiment shown is
representative of four independent experiments.
(C) Quantitative analysis of cytosolic GFP-Salmonella was performed in infected HeLa cells left untreated or transfected with tbk1, gapdh, or control
siRNA. Percent ubiquitin-associated represents the number of bacteria out of 150 counted per experiment that colocalized with ubiquitin at 4 h p.i. from
three independent experiments; * and ** denote p   0.05 and 0.001, respectively, according to a two-tailed Student t-test comparing all samples to
untreated cells.
(D) HeLa cells transfected with tbk1-specific or control siRNA were infected for 1 h with the indicated bacteria, fixed at 4 h p.i., and stained with anti-
LAMP1 antibody. Percent of LAMP-1-associated bacteria was determined by counting the number of bacteria out of 150 per experiment that
colocalized with LAMP-1 as observed by confocal microscopy. The experiment shown is representative of at least two independent experiments; * and
** denote p   0.05 and 0.001, respectively, according to a two-tailed Student t-test comparing tbk1 siRNA-transfected cells to control-transfected cells
for each bacterial strain.
doi:10.1371/journal.ppat.0030029.g004
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TBK1 Restricts Bacterial InfectionWe additionally sought to determine if there was a
requirement for TBK1 in immune effector cells such as
macrophages. We used RNAi to knock down TBK1 expression
in the RAW264.7 macrophage cell line (Figure 5A). It was
previously reported that Salmonella grow poorly in macro-
phage cytosol, so LAMP-1 colocalization was assessed to
reﬂect escape of bacteria from the SCV [32]. At 4 h p.i., in
macrophages treated with tbk1 siRNA, only 62.0% of
Salmonella colocalized with LAMP-1 compared to 94.7%
colocalization in control siRNA-treated cells (Figure 5B and
5C). Tbk1 siRNA treatment of RAW264.7 cells also resulted in
decreased LAMP-1 colocalization with bacteria during
infection by EPEC or S. pyogenes. In contrast, 2-lm beads
taken up by phagocytosis remained completely associated
with LAMP-1 in both tbk1 and control siRNA-treated cells.
From these observations, we conclude that TBK1 regulates
the integrity of pathogen-containing vacuoles in multiple cell
types.
Discussion
We have shown here that the IKK-like kinase, TBK1,
mediates an early cellular response to bacterial infection. In
the absence of TBK1, Salmonella replicated rapidly and to high
levels in MEFs. The IRF3-Type I inteferon axis which
contributes to antiviral immunity was not required for the
growth restrictive function of TBK1, nor was de novo
transcription or translation. After entry into tbk1
 / cells,
Salmonella escaped into the cytosol where proliferation
occurred. Loss of vacuolar integrity in TBK1-deﬁcient cells
was not speciﬁc to Salmonella infection, but occurred during
infection by Gram-negative and Gram-positive pathogenic
bacteria. Thus, TBK1 protects cells during bacterial infection
by conﬁning invading pathogens to a membrane-bound
compartment.
The best studied TBK-dependent signaling pathway trig-
gered by bacterial infection is LPS-mediated induction of
Type I interferons through TLR4, TBK1, and IRF3
[9,11,37,38]. However, our data showed that TBK1 did not
require IRF3 or Type I interferon to exert a protective effect
on host cells during bacterial infection. It is yet unclear
whether TLR4 activation contributes to TBK1-dependent
maintenance of vacuolar integrity. We still observed a
protective effect by TBK1 on pathogen-containing vacuoles
in HeLa cells, which do not express surface TLR4 due to lack
of the accessory protein, MD2 [39]. This observation suggests
Figure 5. Macrophages Require TBK1 to Efficiently Restrict Bacteria in Phagosomes
(A) RAW264.7 macrophages were transfected with the indicated siRNA, and knockdown at 72 h p.i. was determined by Western blot analysis using an
anti-TBK1 antibody. Blots were re-probed with anti-actin antibody as a loading control.
(B) RAW264.7 macrophages transfected with tbk-specific or control siRNA were infected with Salmonella-GFP, fixed at 4 h p.i., and stained with anti-
LAMP1 antibody.
(C) RAW264.7 macrophages transfected with tbk-specific or control siRNA were infected with the indicated bacterial species. Percent LAMP-1-associated
bacteria or beads were determined by counting the number of bacteria or beads out of 150 per experiment that colocalized with LAMP-1 as observed
by confocal microscopy. The experiment shown is representative of at least two independent experiments; * denotes p   0.05, using a two-tailed
Student t-test comparing tbk1 siRNA-transfected cells to control-transfected cells.
doi:10.1371/journal.ppat.0030029.g005
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TBK1 Restricts Bacterial Infectionthat TLR4 signaling is not absolutely required for the
restrictive function of TBK1 in bacterial infection, but
further studies will be necessary to deﬁnitively determine
the role of TLR4 or other TLRs in modulation of vacuolar
integrity by TBK1.
The vacuolar compartment is a restrictive antimicrobial
environment because of its ability to decrease pH, produce
degradative enzymes, and in some cell types, to generate
harmful reactive oxygen species in a conﬁned environment
[40–42]. In contrast, there are few cytosolic antimicrobial
mechanisms, possibly to minimize damage to cytosolic host
machinery. Given the more permissive nature of the host
cytosol, it is surprising that relatively few bacterial pathogens
exploit this intracellular niche [43]. TBK1-dependent mech-
anisms may prevent many bacterial pathogens from accessing
the cytosol by modulating integrity or function of the
endocytic compartment during infection. Our data suggest
two nonexclusive models by which TBK1 may contribute to
the cellular response to bacterial invasion. First, TBK1 could
function at the post-transcriptional level in response to an
infection by phosphorylating target proteins. In the case of
bacterial infection, there may be TBK1 kinase substrates
whose function directly or indirectly modiﬁes the pathogen-
containing vacuole. Secondly, TBK1 may act prior to
infection to establish a state of immune competence, perhaps
by regulating expression of gene products that are important
for the immediate response to bacterial invasion. This model
requires that TBK1 have some constitutive activity prior to
infection. Since there is a known requirement for TBK1 in
embryonic development in the absence of infection, it is
likely that TBK1 may function in normal adult animals in the
absence of infection as well [5–7]. Indeed, two recent studies
have identiﬁed TBK1 as a regulator of angiogenesis and
oncogenesis [44,45]. Furthermore, microarray analysis of
uninfected tbk1
þ/þ and tbk1
 /  MEFs identiﬁed over 400 genes
that were differentially expressed, some of which have known
associations with innate immune function (ALR and MXDO,
unpublished data).
At the molecular level, there are at least two mechanisms by
which TBK1 may ultimately regulate vacuolar integrity. In
response to bacterial invasion, TBK1 could control initiation
of autophagy, which can capture bacteria in damaged
vacuoles [46,47]. This possibility is less likely, as colocalization
with LC3, a marker of autophagosomes, was slightly higher in
infected tbk
 / cells than wild-type cells. However, it is notable
that all of the bacterial species, for which we showed cytosolic
localization in tbk1
 /  cells, have mechanisms by which
vacuolar membranes are damaged during infection, i.e.,
Salmonella and EPEC contain Type III secretion machinery,
and S. pyogenes encodes the pore-forming toxin Streptolysin O
[48–50]. Alternatively, a TBK1-dependent target could mod-
ulate inﬂux/efﬂux of ions or water into the pathogen-
containing vacuole to maintain its physical continuity or
otherwise alter membrane dynamics in response to infection.
Previous studies have demonstrated that host cells activate
repair mechanisms in response to membrane damage [51,52].
Our ﬁndings are consistent with damage to the vacuolar
membrane as a possible trigger for TBK1-dependent function
during bacterial infection.
The innate immune system is required both for controlling
pathogen replication and for communicating with other cell
types. In viral infections, TBK1 clearly acts as a regulator of
innate immunity by communicating with other cells through
Type I interferon, which contributes to control of viral
replication. However, we have demonstrated that in bacterial
infections, TBK1 plays an important role in limiting
pathogen replication by protecting the integrity of the
pathogen-containing vacuole, independently of Type I
interferon. Our ﬁndings do not preclude an additional
requirement for TBK1 in antibacterial immunity through
stimulation of cytokine or chemokine expression, but suggest
an early TBK1-dependent mechanism by which host cells can
achieve innate control of bacterial infection.
Supporting Information
Figure S1. Trafﬁcking of Salmonella Populations in tbk1
 /  MEFs
(A) Tbk1
þ/þ and tbk1
 /  MEFs were transfected with a LC3-GFP-
expressing plasmid (green) to identify autophagosomes and infected
with Salmonella-RFP (red). Infected cells were ﬁxed at 1 h p.i. and
analyzed by confocal microscopy. Percent colocalization was deter-
mined by counting how many bacteria out of 100 per experiment that
colocalized with LC3-GFP (n ¼ 3). White arrowheads point to
Salmonella colocalized with LC3-GFP, white outlined arrowheads
point to bacteria not colocalized with LC3-GFP.
(B) Tbk1
þ/þ and tbk1
 /  MEFs were treated with Lysotracker (a dye that
ﬂuoresces in acidic compartments) and infected with Salmonella-GFP
(green). Infected cells were ﬁxed 1 h p.i. and analyzed by confocal
microscopy. Percent colocalization was determined by counting the
number of bacteria out of 150 bacteria that colocalized with bright
red acidic compartments.
Found at doi:10.1371/journal.ppat.0030029.sg001 (10 MB PDF).
Figure S2. Validation of rIFN-b Stimulation and a-Amanitin
Inhibition in MEFs Infected with Salmonella
(A) Quantitative RT-PCR was performed to determine mx1 induction
in uninfected, 1 h, and 8 h Salmonella-infected MEFs in the presence of
100 U/ml rIFN-b normalized to uninfected untreated cells. ** denotes
p   0.001, according to a two-tailed Student t-test comparing rIFN-b-
treated samples to an untreated sample of the same genotype.
(B) Salmonella intracellular growth curve in tbk1
þ/þ (gray triangles) and
tbk1
 /  (black squares) MEFs was measured over time in the absence
(solid lines) or presence (dashed lines) of the RNA polymerase II
inhibitor, a-amanitin. Where indicated, MEFs were treated with 50
lg/ml a-amanitin 1 h prior to and during infection. The data shown
are representative of three independent experiments.
(C) Quantitative RT-PCR was performed to assess ip10 induction in
uninfected and 8 h Salmonella-infected tbk1
þ/þMEFs in the presence or
absence of a-amanitin (50 lg/ml). ** denotes p   0.001, according to a
two-tailed Student t-test comparing infected untreated and a-
amanitin-treated cells to uninfected cells.
Found at doi:10.1371/journal.ppat.0030029.sg002 (271 KB PDF).
Figure S3. Kinetic Analysis of LAMP-1 Colocalization with Salmonella
in tbk1
þ/þ and tbk1
 /  MEFs
Tbk1
þ/þ and tbk1
 /  MEFs were infected with Salmonella-GFP (green).
Infected cells were ﬁxed at 2, 4, and 6 h p.i., stained with anti-LAMP-1
antibody followed by a TRITC-labeled secondary antibody (red), and
analyzed by confocal immunoﬂuorescence microscopy. Percent
colocalization was determined by counting the number of bacteria
out of 150 bacteria per experiment that colocalized with LAMP-1.
The experiment shown is representative of three independent
experiments.
Found at doi:10.1371/journal.ppat.0030029.sg003 (7.2 MB PDF).
Figure S4. A Salmonella sifA Mutant Strain and EPEC Display Similar
Growth and Vacuolar Escape as Wild-Type Salmonella in tbk1
 /  MEFs
(A) MEFs were infected for 1 h with the indicated bacterial strains and
then ﬁxed at 2, 3, or 4 h p.i. Results from tbk1
þ/þ MEFs are shown in
gray bars and tbk1
 /  MEFs are shown in black bars. Samples were
stained as in Figure 4B. Percent ubiquitin-associated represents the
number of bacteria out of 150 counted per experiment that
colocalized with ubiquitin from two to three independent experi-
ments. * and ** denote p   0.05 and 0.001, respectively, according to
a two-tailed Student t-test comparing each time point of tbk1
 /  to
tbk1
þ/þ for each bacterial strain.
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TBK1 Restricts Bacterial Infection(B) Intracellular growth of wild-type Salmonella (St; solid lines) or a
DsifA mutant strain (StDsifA; dashed lines) was measured over time in
tbk1
þ/þ (triangles) and tbk1
 /  (squares) MEFs. The data are represen-
tative of four independent experiments.
(C) Intracellular growth of EPEC was measured over time in tbk1
þ/þ
(triangles) and tbk1
 /  (squares) MEFs. * denotes a p-value of   0.05,
according to a one-tailed Student t-test comparing tbk1
 / to tbk1
þ/þat
each time point. The data are representative of three independent
experiments.
Found at doi:10.1371/journal.ppat.0030029.sg004 (273 KB PDF).
Figure S5. A Salmonella SPI-1 Mutant Remains in LAMP-1
þ Vacuoles
in tbk1
þ/þ and tbk1
 /  MEFs throughout Infection
(A) Tbk1
þ/þ and tbk1
 /  MEFs were infected with St SPI-1
 -GFP (green)
in the presence of wild-type Salmonella to induce bystander uptake.
Infected cells were ﬁxed at 4 h p.i., stained with DAPI (blue) and an
anti-LAMP-1 antibody, followed by a TRITC-labeled secondary
antibody (red) prior to analysis by confocal microscopy. Percent
colocalization was determined by counting the number of GFP
þ
bacteria (SPI-1
 ) out of 150 GFP
þ bacteria colocalized with LAMP-1.
The data are representative of three independent experiments.
(B) Tbk1
þ/þ and tbk1
 /  MEFs were treated with Lysotracker, a dye that
ﬂuoresces brightly in acidic compartments, and subsequently infected
with St SPI-1
 -GFP (green) in the presence of wild-type Salmonella to
induce bystander uptake. Infected cells were ﬁxed 1 h p.i. and
analyzed by confocal microscopy.
(C) MEFs were treated with Lysotracker, infected with either wild-
type Salmonella-GFP or St SPI-1
 -GFP in the presence of wild-type
unmarked Salmonella (Salmonella) to induce bystander uptake for 1 h
and ﬁxed at 1 h and 4 h p.i. Percent Lysotracker-associated bacteria
was determined by counting the number of GFP
þ bacteria out of 150
GFP
þ bacteria per experiment that colocalized with bright red acidic
compartments as observed via confocal microscopy (n ¼ 3).
Found at doi:10.1371/journal.ppat.0030029.sg005 (9.4 MB PDF).
Table S1. Bacterial Strains Used in This Study
Found at doi:10.1371/journal.ppat.0030029.st001 (17 KB PDF).
Accession Numbers
The DNA sequences used for primer design in this study from the
NCBI Entrez Nucleotide sequence database (http://www.ncbi.nlm.nih.
gov/entrez/query.fcgi?db¼Nucleotide) are actin (NM_007393), ip10
(NC_00071), mx1 (NM_010846), and tbk1 (NC_00076.4).
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